This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
View All Zacks #1 Ranked Stocks
Zacks News
UVV or BTI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UVV vs. BTI: Which Stock Is the Better Value Option?
Altria Stock Trading at a Discount to Industry: Buy or Hold?
by Swati Prasad
MO trades at a steep discount with steady gains, but its momentum rests on pricing power, brand strength and managing persistent volume declines.
UVV vs. BTI: Which Stock Is the Better Value Option?
by Zacks Equity Research
UVV vs. BTI: Which Stock Is the Better Value Option?
Should You Bet on Altria Stock After Its Q3 Earnings Report?
by Swati Prasad
MO is backed by strong fundamentals, pricing power and long-term growth potential in smoke-free products.
UVV or BTI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UVV vs. BTI: Which Stock Is the Better Value Option?
Should You Consider Buying Altria Stock Before Q3 Earnings Release?
by Vrishali Bagree
MO's Q3 results are likely to gain strength from pricing power, cost discipline and growing smoke-free momentum.
Altria Rises 12% in 3 Months: Should You Buy, Sell or Hold the Stock?
by Swati Prasad
MO's 12% 3-month surge highlights strong earnings, rising smoke-free sales and disciplined execution amid industry weakness.
Altria Stock Trading at a Discount: What's the Next Best Move?
by Swati Prasad
MO shows steady earnings and strong pricing power, though long-term momentum depends on balancing cigarette declines with smoke-free gains.
Should You Buy Altria Stock as it Hits a New 52-Week High?
by Swati Prasad
MO hits a 52-week high on earnings growth, oral tobacco gains and rising investor confidence in its long-term strategy.
PM Stock Trades at Premium Value: Should You Buy, Hold or Sell?
by Swati Prasad
Philip Morris' smoke-free growth is strong, but cigarette declines and a premium valuation urge cautious investment moves.